Login / Signup

Neurocognitive Disorders Associated with PCSK9 Inhibitors: a Pharmacovigilance Disproportionality Analysis.

Amandine GouverneurPaola Sanchez-PenaGwenaelle VeyracJoe-Elie SalemBernard BégaudJulien Bezin
Published in: Cardiovascular drugs and therapy (2021)
This study identified a signal of neurocognitive disorders associated with PCSK9 inhibitors and encourages paying attention to at-risk populations.
Keyphrases
  • bipolar disorder
  • adverse drug
  • emergency department
  • electronic health record